An agriculture biotech company that markets high-fiber wheat said it is expanding its hemp subsidiary with a $10 million stock offering.
Arcadia Biosciences of Davis, California, plans to use the money to research hemp genetics in Imperial County, California, according to a news release.
The company’s hemp subsidiary, Arcadia Specialty Genomics, is scheduled to start planting hemp there Oct. 1.
Arcadia started its hemp subsidiary in April in Hawaii, where hemp growers had to destroy more than 50% of the state’s 2019 hemp crop because varieties exceeded the THC limit of 0.3%.
Arcadia CEO Matthew Plavan said in the release that hemp is “decades behind other crops” in the availability of commercially viable seeds.
“It’s very difficult to purchase a batch of uniform CBD hempseed, resulting in unpredictable outcomes for both growers and buyers,” Plavan said.
Arcadia trades on the Nasdaq as RKDA.
For analysis and in-depth looks at the investment trends and deals driving the cannabis industry forward, sign up for our premium subscription service, Investor Intelligence.
Subscribe to our Newsletter
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers